A detailed history of North Star Asset Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, North Star Asset Management Inc holds 157,215 shares of ABBV stock, worth $26.8 Million. This represents 1.33% of its overall portfolio holdings.

Number of Shares
157,215
Previous 154,025 2.07%
Holding current value
$26.8 Million
Previous $28 Million 3.86%
% of portfolio
1.33%
Previous 1.38%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$154.79 - $180.76 $493,780 - $576,624
3,190 Added 2.07%
157,215 $27 Million
Q1 2024

May 08, 2024

BUY
$159.82 - $182.1 $250,917 - $285,897
1,570 Added 1.03%
154,025 $28 Million
Q4 2023

Feb 01, 2024

BUY
$137.6 - $154.97 $251,532 - $283,285
1,828 Added 1.21%
152,455 $23.6 Million
Q3 2023

Oct 26, 2023

BUY
$133.59 - $154.65 $63,188 - $73,149
473 Added 0.32%
150,627 $22.5 Million
Q2 2023

Aug 09, 2023

BUY
$132.51 - $164.9 $629,157 - $782,945
4,748 Added 3.27%
150,154 $20.2 Million
Q1 2023

May 10, 2023

BUY
$144.61 - $166.54 $26,752 - $30,809
185 Added 0.13%
145,406 $23.2 Million
Q4 2022

Mar 06, 2023

SELL
$138.31 - $165.87 $36,513 - $43,789
-264 Reduced 0.18%
145,221 $23.5 Million
Q3 2022

Nov 08, 2022

BUY
$134.21 - $153.93 $472,150 - $541,525
3,518 Added 2.48%
145,485 $19.5 Million
Q2 2022

Jul 28, 2022

SELL
$137.62 - $174.96 $299,048 - $380,188
-2,173 Reduced 1.51%
141,967 $21.7 Million
Q1 2022

Apr 29, 2022

BUY
$131.98 - $163.75 $25,076 - $31,112
190 Added 0.13%
144,140 $23.4 Million
Q4 2021

Feb 07, 2022

BUY
$107.43 - $135.93 $765,761 - $968,909
7,128 Added 5.21%
143,950 $19.5 Million
Q3 2021

Oct 20, 2021

BUY
$106.4 - $120.78 $1.87 Million - $2.12 Million
17,551 Added 14.72%
136,822 $14.8 Million
Q2 2021

Jul 30, 2021

BUY
$105.21 - $117.21 $591,701 - $659,189
5,624 Added 4.95%
119,271 $13.4 Million
Q1 2021

Apr 29, 2021

BUY
$102.3 - $112.62 $2.46 Million - $2.71 Million
24,072 Added 26.87%
113,647 $12.3 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $1.31 Million - $1.77 Million
16,266 Added 22.19%
89,575 $9.6 Million
Q3 2020

Nov 02, 2020

BUY
$85.91 - $100.83 $440,804 - $517,358
5,131 Added 7.53%
73,309 $6.42 Million
Q2 2020

Jul 28, 2020

BUY
$73.37 - $98.18 $1.5 Million - $2.01 Million
20,471 Added 42.91%
68,178 $6.69 Million
Q1 2020

Apr 24, 2020

BUY
$64.5 - $97.79 $417,508 - $632,994
6,473 Added 15.7%
47,707 $3.64 Million
Q4 2019

Feb 06, 2020

BUY
$72.13 - $90.25 $313,044 - $391,685
4,340 Added 11.76%
41,234 $3.65 Million
Q3 2019

Oct 25, 2019

BUY
$62.98 - $75.72 $211,927 - $254,797
3,365 Added 10.04%
36,894 $2.79 Million
Q2 2019

Aug 12, 2019

BUY
$65.7 - $83.98 $117,274 - $149,904
1,785 Added 5.62%
33,529 $2.44 Million
Q1 2019

Apr 26, 2019

BUY
$77.14 - $90.79 $24,299 - $28,598
315 Added 1.0%
31,744 $2.56 Million
Q4 2018

Jan 29, 2019

BUY
$77.85 - $96.01 $2,724 - $3,360
35 Added 0.11%
31,429 $2.9 Million
Q3 2018

Oct 29, 2018

SELL
$88.91 - $98.84 $100,912 - $112,183
-1,135 Reduced 3.49%
31,394 $2.97 Million
Q2 2018

Aug 10, 2018

SELL
$89.78 - $106.23 $74,966 - $88,702
-835 Reduced 2.5%
32,529 $3.01 Million
Q1 2018

Apr 27, 2018

SELL
$92.01 - $123.21 $95,598 - $128,015
-1,039 Reduced 3.02%
33,364 $3.16 Million
Q4 2017

Feb 01, 2018

BUY
$89.56 - $98.21 $1.54 Million - $1.69 Million
17,218 Added 100.19%
34,403 $3.33 Million
Q3 2017

Oct 25, 2017

BUY
$69.85 - $89.22 $10,826 - $13,829
155 Added 0.91%
17,185 $1.53 Million
Q3 2017

Oct 25, 2017

SELL
$69.85 - $89.22 $10,477 - $13,383
-150 Reduced 0.87%
17,030 $1.11 Million
Q2 2017

Aug 16, 2017

BUY
N/A
17,180
17,180 $1.25 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track North Star Asset Management Inc Portfolio

Follow North Star Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on North Star Asset Management Inc with notifications on news.